GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia

[1]  Y. Furukawa.  GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia , 2015 .

[2]  A. Singleton,et al.  Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to l-DOPA treatment , 2013, Journal of Neurology.

[3]  James P Evans,et al.  An informatics approach to analyzing the incidentalome , 2012, Genetics in Medicine.

[4]  Muin J Khoury,et al.  Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.

[5]  A. Hingorani,et al.  Endothelial, Sympathetic, and Cardiac Function in Inherited (6R)-L-Erythro-5,6,7,8-Tetrahydro-L-Biopterin Deficiency , 2010, Circulation. Cardiovascular genetics.

[6]  S. Bressman,et al.  High mutation rate in dopa-responsive dystonia: Detection with comprehensive GCHI screening , 2005, Neurology.

[7]  A. Lang,et al.  Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? , 2002, Journal of neurology, neurosurgery, and psychiatry.

[8]  H. Topka,et al.  Dopa-responsive dystonia: Mutation analysis of GCH1 and analysis of therapeutic doses of l-dopa , 2000, Neurology.

[9]  Y. Agid,et al.  Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? , 2000, Brain : a journal of neurology.

[10]  S. Kish,et al.  Dopa-responsive Dystonia , 2004 .

[11]  C. Marsden,et al.  Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. , 1996, Human molecular genetics.

[12]  Stanley Fahn,et al.  Linkage mapping of dopa–responsive dystonia (DRD) to chromosome 14q , 1993, Nature Genetics.